First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2014-07-14 10:29:27Open Document File Size: 232,22 KBShare Result on FacebookCompanyMerck & Co. Inc. / Flagship Ventures / Johnson & Johnson Pharmaceuticals / Merck Research Laboratories / Tibotec Pharmaceuticals Inc. / Seres Health / Infectious Diseases / /FacilityMassachusetts General Hospital / Whitehead Institute / Thomas Jefferson University / Massachusetts Institute of Technology / Johns Hopkins University / laboratory of Nobel Laureate / /MedicalConditionInfectious Diseases / /OrganizationJohns Hopkins School of Medicine / Harvard Medical School / the Johns Hopkins University / Whitehead Institute / Medical School in Philadelphia / Institute for Human Virology and Biodefense / Massachusetts General Hospital / Massachusetts Institute of Technology / Thomas Jefferson University / /PersonRoger Pomerantz / Molecular Pharmacology / David Baltimore / / /PositionPresident / Chief Executive Officer and Chairman / Global Head / President / Vice President and Worldwide Head of Licensing & Acquisitions / strategic counsel / Senior Partner / Chief / Founding Director and Chair / Vice President and Global Franchise Head / Professor of Medicine / Global Head of Infectious Diseases / /ProvinceOrStateMassachusetts / /URLwww.flagshipventures.com / /SocialTag |